Over-the-Counter Monograph Drug User Fee Amendments

This bill appears to deal with fees that companies pay to the government related to over-the-counter drugs that are sold without a prescription and are approved through a process called a monograph, which sets standard rules for certain drug ingredients and labels. It likely proposes changes or updates to those user fee arrangements. No official summary is available for this bill.

Your Vote